1-7 of 7
Gerald Wulf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas

Open Access
Nicole Schmidt, Kevin Kornrumpf, Lena Ries, Katharina Markus, Nora Anna Maria Ksionsko, Paolo Mazzeo, Melanie Lohrberg, Maren Sitte, Gabriela Salinas, Till Braun, Annika Dechow, Marco Herling, Aleksandr Ianevski, Tero Aittokallio, Björn Chapuy, Holger Bastians, Gerald Wulf, Tim Beißbarth, Jürgen Dönitz, Raphael Koch
Journal: Blood Advances
Blood Adv (2025) 9 (20): 5327–5340.
https://doi.org/10.1182/bloodadvances.2024015167
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma

Open Access
Evgenii Shumilov, Julia Katharina Scholz, Maximilian Seib, Paolo Mazzeo, Rebecca Wurm-Kuczera, Vladan Vucinic, Udo Holtick, Hristo Boyadzhiev, Thomas Melchardt, Alexander Hölscher, Christian Schultze-Florey, Atef Abdelhafez, Giuliano Filippini Velazquez, Anna Ossami Saidy, Vadim Lesan, Ulf Schnetzke, Andrea Kerkhoff, Ulrike Bacher, Susanne Ghandili, Enver Aydilek, Niklas Gebauer, Thomas Weber, Gerald Wulf, Bertram Glass, Lorenz Thurner, Florian H. Heidel, Christoph Schmid, Andreas Viardot, Mathias Hänel, Sascha Dietrich, Thomas Pabst, Francis Ayuk, Bastian von Tresckow, Björn Chapuy, Christiane Pott, Fabian Müller, Georg Lenz
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3955–3966.
https://doi.org/10.1182/bloodadvances.2024015719
Published: 2025
Includes: Supplemental data
Journal Articles

Measurable residual disease monitoring in AML with FLT3 -ITD treated with intensive chemotherapy plus midostaurin

Free
Frank G. Rücker, Lars Bullinger, Sibylle Cocciardi, Sabrina Skambraks, Tamara J. Luck, Daniela Weber, Julia Krzykalla, Ema Pozek, Isabelle Schneider, Andrea Corbacioglu, Verena I. Gaidzik, Annika Meid, Sophia Aicher, Frank Stegelmann, Anika Schrade, Frauke Theis, Walter Fiedler, Helmut R. Salih, Gerald Wulf, Hans Salwender, Thomas Schroeder, Katharina S. Götze, Michael W. M. Kühn, Michael Lübbert, Richard F. Schlenk, Axel Benner, Felicitas Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhner
Journal: Blood Advances
Blood Adv (2024) 8 (23): 6067–6080.
https://doi.org/10.1182/bloodadvances.2024013758
Published: 2024
Includes: Supplemental data
Journal Articles

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study

Free
Maria-Luisa Schubert, Wolfgang A. Bethge, Francis A. Ayuk, Malte von Bonin, Vladan Vucinic, Eva Marie Wagner-Drouet, Marion Subklewe, Claudia D. Baldus, Bertram Glass, Reinhard Marks, Dimitrios Mougiakakos, Roland Schroers, Matthias Stelljes, Max S. Topp, Gerald Wulf, Nicolaus Kröger, Peter Dreger
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6191–6195.
https://doi.org/10.1182/bloodadvances.2023011203
Published: 2023
Includes: Supplemental data
Journal Articles

Real-world results of CAR T-cell therapy for large B-cell lymphoma with CNS involvement: a GLA/DRST study

Free
Clinical Trials & Observations
Francis Ayuk, Nico Gagelmann, Bastian von Tresckow, Gerald Wulf, Kai Rejeski, Matthias Stelljes, Olaf Penack, Claudia D. Baldus, Nicolaus Kröger, Wolfgang Bethge, Peter Dreger
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5316–5319.
https://doi.org/10.1182/bloodadvances.2023010336
Published: 2023
Includes: Supplemental data
Journal Articles

Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications

Free
Clinical Trials & Observations
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Helmut Salih, Michael Lübbert, Michael W. M. Kühn, Thomas Schroeder, Hans Salwender, Katharina Götze, Jörg Westermann, Lars Fransecky, Karin Mayer, Bernd Hertenstein, Mark Ringhoffer, Hans-Joachim Tischler, Sigrid Machherndl-Spandl, Anika Schrade, Peter Paschka, Verena I. Gaidzik, Frauke Theis, Felicitas Thol, Michael Heuser, Richard F. Schlenk, Lars Bullinger, Maral Saadati, Axel Benner, Richard Larson, Richard Stone, Konstanze Döhner, Arnold Ganser
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5345–5355.
https://doi.org/10.1182/bloodadvances.2022007223
Published: 2022
Includes: Supplemental data
Journal Articles

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Free
Clinical Trials & Observations
Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Eva Kaebisch, Fabian Acker, Stephan Fuhrmann, Corinna Leng, Manfred Welslau, Jens Chemnitz, Jan-Moritz Middeke, Thomas Weber, Udo Holtick, Ralf Trappe, Roald Pfannes, Ruediger Liersch, Christian Spoer, Stefan Fuxius, Niklas Gebauer, Léandra Caillé, Thomas Geer, Christian Koenecke, Ulrich Keller, Rainer Claus, Dimitrios Mougiakakos, Stephanie Mayer, Andreas Huettmann, Christiane Pott, Arne Trummer, Gerald Wulf, Uta Brunnberg, Lars Bullinger, Georg Hess, Carsten Mueller-Tidow, Bertram Glass, Georg Lenz, Peter Dreger, Sascha Dietrich
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2707–2716.
https://doi.org/10.1182/bloodadvances.2020004155
Published: 2021
Includes: Supplemental data